Anthera Pharmaceuticals Provides Business Update and Reports 2016 First Quarter Financial Results

Go back to Anthera Pharmaceuticals Provides Business Update and Reports 2016 First Quarter Financial Results

Anthera Pharma (ANTH) Misses Q1 EPS by 1c

May 9, 2016 8:40 AM EDT

Anthera Pharma (NASDAQ: ANTH) reported Q1 EPS of ($0.29), $0.01 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.

... More